Rifampicin-induced thrombocytopenia

In the treatment of tuberculosis there are special therapeutic problems related to adverse effects of drugs, compliance to treatment, and microbial resistance. Thrombocytopenia is an uncommon but potentially fatal adverse effect of certain anti-tubercular drugs when the incriminating drug is taken b...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Ajay Kumar, Singh, Arpita, Chandra, Amol, Kumar, Santosh, Gupta, Rajesh Kumar
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941616/
https://www.ncbi.nlm.nih.gov/pubmed/20927251
http://dx.doi.org/10.4103/0253-7613.68432
_version_ 1782186919734542336
author Verma, Ajay Kumar
Singh, Arpita
Chandra, Amol
Kumar, Santosh
Gupta, Rajesh Kumar
author_facet Verma, Ajay Kumar
Singh, Arpita
Chandra, Amol
Kumar, Santosh
Gupta, Rajesh Kumar
author_sort Verma, Ajay Kumar
collection PubMed
description In the treatment of tuberculosis there are special therapeutic problems related to adverse effects of drugs, compliance to treatment, and microbial resistance. Thrombocytopenia is an uncommon but potentially fatal adverse effect of certain anti-tubercular drugs when the incriminating drug is taken by a susceptible individual. We report a case of rifampicin-induced thrombocytopenia, which although rare, needs attention.
format Text
id pubmed-2941616
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29416162010-10-06 Rifampicin-induced thrombocytopenia Verma, Ajay Kumar Singh, Arpita Chandra, Amol Kumar, Santosh Gupta, Rajesh Kumar Indian J Pharmacol Case Report In the treatment of tuberculosis there are special therapeutic problems related to adverse effects of drugs, compliance to treatment, and microbial resistance. Thrombocytopenia is an uncommon but potentially fatal adverse effect of certain anti-tubercular drugs when the incriminating drug is taken by a susceptible individual. We report a case of rifampicin-induced thrombocytopenia, which although rare, needs attention. Medknow Publications 2010-08 /pmc/articles/PMC2941616/ /pubmed/20927251 http://dx.doi.org/10.4103/0253-7613.68432 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Verma, Ajay Kumar
Singh, Arpita
Chandra, Amol
Kumar, Santosh
Gupta, Rajesh Kumar
Rifampicin-induced thrombocytopenia
title Rifampicin-induced thrombocytopenia
title_full Rifampicin-induced thrombocytopenia
title_fullStr Rifampicin-induced thrombocytopenia
title_full_unstemmed Rifampicin-induced thrombocytopenia
title_short Rifampicin-induced thrombocytopenia
title_sort rifampicin-induced thrombocytopenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941616/
https://www.ncbi.nlm.nih.gov/pubmed/20927251
http://dx.doi.org/10.4103/0253-7613.68432
work_keys_str_mv AT vermaajaykumar rifampicininducedthrombocytopenia
AT singharpita rifampicininducedthrombocytopenia
AT chandraamol rifampicininducedthrombocytopenia
AT kumarsantosh rifampicininducedthrombocytopenia
AT guptarajeshkumar rifampicininducedthrombocytopenia

Ejemplares similares